Shopping Cart
- Remove All
- Your shopping cart is currently empty
EPZ020411 is a potent and selective PRMT6 inhibitor tool compound. EPZ020411 shows good bioavailability following subcutaneous dosing in rats making it a suitable tool for in vivo studies. EPZ020411 suppresses RCC1 arginine methylation and improves the cytotoxic activity of radiotherapy against GSC brain tumor xenografts.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $6,839 | 1-2 weeks | |
50 mg | $9,568 | 1-2 weeks | |
100 mg | $13,398 | 1-2 weeks |
Description | EPZ020411 is a potent and selective PRMT6 inhibitor tool compound. EPZ020411 shows good bioavailability following subcutaneous dosing in rats making it a suitable tool for in vivo studies. EPZ020411 suppresses RCC1 arginine methylation and improves the cytotoxic activity of radiotherapy against GSC brain tumor xenografts. |
Molecular Weight | 515.52 |
Formula | C25H40Cl2N4O3 |
Cas No. | 2095432-47-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.